Hypothyroidism as a Consequence of Intensity-Modulated Radiotherapy With Concurrent Taxane-Based Chemotherapy for Locally Advanced Head-and-Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 468-476

  Diaz, Roberto ^a   Jaboin, Jerry J ^a   Morales Paliza, Manuel ^a   Koehler, Elizabeth ^b   Phillips, John G ^a   Stinson, Scott ^a   Gilbert, Jill ^c   Chung, Christine H ^c   Murphy, Barbara A ^c   Yarbrough, Wendell G ^d   Murphy, Patrick B ^e   Shyr, Yu ^b   Cmelak, Anthony J ^a  

^a Department of Radiation Oncology ^*  (United States)

^b Department of Medicine   (United States)

^c Section of Hematology/Oncology   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e Tennessee Oncology   (United States)

Author keywords

Concurrent chemoradiation; Head and neck cancer; Hypothyroidism; IMRT; Radiation side effects

Indexed keywords

AREA UNDER THE CURVES; CARBOPLATIN; CERVICAL NODES; CONCURRENT CHEMORADIATION; DOSE-VOLUME HISTOGRAMS; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY; PACLITAXEL; RADIATION DOSE; RE-PLANNING; RISK FACTORS; SIDE EFFECT; THYROID TISSUE; THYROID VOLUME;

CHEMOTHERAPY; DOSIMETRY; PATIENT MONITORING; PHYSICAL THERAPY; RADIATION EFFECTS; RADIOTHERAPY;

THREE DIMENSIONAL;

CARBOPLATIN; PACLITAXEL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOTHYROIDISM; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LOCALLY ADVANCED HEAD AND NECK CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; THYROID GLAND;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRIDGED COMPOUNDS; CARBOPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PACLITAXEL; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; TAXOIDS; THYROID GLAND;

EID: 77951790577     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.018     Document Type: Article

References (43)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2008. CA Cancer J Clin 58 (2008) 71-96
2. Marur S., and Forastiere A.A. Head and neck cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 83 (2008) 489-501
3. Chao K.S., Ozyigit G., and Thorsdad W.L. Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine. Semin Oncol 30 (2003) 101-108
4. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: Matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1309-1317
5. Lee N., Puri D.R., Blanco A.I., et al. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 29 (2007) 387-400
6. Lee N.Y., de Arruda F.F., Puri D.R., et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 966-974
7. Yang ES, Murphy BM, Chung CH, et al. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol. In press.
8. Parliament M., Alidrisi M., Munroe M., et al. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Int J Oral Maxillofac Surg 34 (2005) 114-121
9. Caglar H.B., and Allen A.M. Intensity-modulated radiotherapy for head and neck cancer. Clin Adv Hematol Oncol 5 (2007) 425-431
10. Mendenhall W.M., Amdur R.J., and Palta J.R. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 24 (2006) 2618-2623
11. Colevas A.D., Read R., Thornhill J., et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 51 (2001) 599-604
12. Constine L.S., Donaldson S.S., McDougall I.R., et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 53 (1984) 878-883
13. Grande C. Hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors. Radiother Oncol 25 (1992) 31-36
14. Hancock S.L., Cox R.S., and McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325 (1991) 599-605
15. Hancock S.L., McDougall I.R., and Constine L.S. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 31 (1995) 1165-1170
16. Jereczek-Fossa B.A., Alterio D., Jassem J., et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 30 (2004) 369-384
17. Mercado G., Adelstein D.J., Saxton J.P., et al. Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 92 (2001) 2892-2897
18. Tell R., Lundell G., Nilsson B., et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 60 (2004) 395-400
19. Tell R., Sjodin H., Lundell G., et al. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39 (1997) 303-308
20. Sunwoo J.B., Herscher L.L., Kroog G.S., et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 19 (2001) 800-811
21. Kumpulainen E.J., Hirvikoski P.P., Virtaniemi J.A., et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol 57 (2000) 97-101
22. Liening D.A., Duncan N.O., Blakeslee D.B., et al. Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 103 (1990) 10-13
23. Ozawa H., Saitou H., Mizutari K., et al. Hypothyroidism after radiotherapy for patients with head and neck cancer. Am J Otolaryngol 28 (2007) 46-49
24. Posner M.R., Ervin T.J., Miller D., et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope 94 (1984) 451-454
25. Sinard R.J., Tobin E.J., Mazzaferri E.L., et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg 126 (2000) 652-657
26. Turner S.L., Tiver K.W., and Boyages S.C. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 31 (1995) 279-283
27. Bhandare N., Kennedy L., Malyapa R.S., et al. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 68 (2007) 1131-1139
28. Norris A.A., Amdur R.J., Morris C.G., et al. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol 29 (2006) 442-445
29. Alterio D., Jereczek-Fossa B.A., Franchi B., et al. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: A retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys 67 (2007) 144-150
30. Bethge W., Guggenberger D., Bamberg M., et al. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol 79 (2000) 114-118
31. Garcia-Serra A., Amdur R.J., Morris C.G., et al. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 28 (2005) 255-258
32. Lo Galbo A.M., de Bree R., Kuik D.J., et al. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: Are autoantibodies of influence?. Acta Otolaryngol 127 (2007) 312-317
33. Nishiyama K., Tanaka E., Tarui Y., et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys 34 (1996) 439-444
34. Nishiyama K., Kozuka T., Higashihara T., et al. Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 36 (1996) 1221-1224
35. Yoden E., Soejima T., Maruta T., et al. (Hypothyroidism after radiotherapy to the neck). Nippon Igaku Hoshasen Gakkai Zasshi 64 (2004) 146-150
36. Duggan D., Murphy B.A., Beach M., et al. Intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer(LAHNC): Feasibility, technique, and toxicities. J Clin Oncol 23 (2005) 509s-509s
37. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
38. Team RDC. R: A language and environment for statistical computing. Available at: http://www.R-project.org. Accessed June 16, 2009.
39. Weissler M.C., and Berry B.W. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 13 (1991) 420-423
40. Kuten A., Lubochitski R., Fishman G., et al. Postradiotherapy hypothyroidism: Radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 61 (1996) 281-283
41. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
42. Posner M.R., Weichselbaum R.R., Fitzgerald T.J., et al. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 11 (1985) 1887-1893
43. Vrabec D.P., and Heffron T.J. Hypothyroidism following treatment for head and neck cancer. Ann Otol Rhinol Laryngol 90 (1981) 449-453